A perinatal nitric oxide donor increases renal vascular resistance and ameliorates hypertension and glomerular injury in adult fawn-hooded hypertensive rats
Authors:
- Maarten P. KoenersMKMaarten P. Koeners
- Branko BraamBBBranko Braam
- Dionne M. van der GiezenDGDionne M. van der Giezen
- Roel GoldschmedingRGRoel Goldschmeding
- Jaap A. JolesJJJaap A. Joles
- 1 June 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 294 (6) , R1847-R1855
Abstract
Enhancing perinatal nitric oxide (NO) availability persistently reduces blood pressure in spontaneously hypertensive rats. We hypothesize that this approach can be generalized to other models of genetic hypertension, for instance those associated with renal injury. Perinatal exposure to the NO donor molsidomine was studied in fawn-hooded hypertensive (FHH) rats, a model of mild hypertension, impaired preglomerular resistance, and progressive renal injury. Perinatal molsidomine increased urinary NO metabolite excretion at 8 wk of age, i.e., 4 wk after treatment was stopped ( P < 0.05). Systolic blood pressure was persistently reduced after molsidomine (42-wk females: 118 ± 3 vs. 141 ± 5 and 36-wk males: 139 ± 4 vs. 158 ± 4 mmHg; both P < 0.001). Perinatal treatment decreased glomerular filtration rate ( P < 0.05) and renal blood flow ( P < 0.01) and increased renal vascular resistance ( P < 0.05), without affecting filtration fraction, suggesting persistently increased preglomerular resistance. At 4 wk of age natriuresis was transiently increased by molsidomine ( P < 0.05). Molsidomine decreased glomerulosclerosis ( P < 0.05). Renal blood flow correlated positively with glomerulosclerosis in control ( P < 0.001) but not in perinatally treated FHH rats. NO dependency of renal vascular resistance was increased by perinatal molsidomine. Perinatal enhancement of NO availability can ameliorate development of hypertension and renal injury in FHH rats. Paradoxically, glomerular protection by perinatal exposure to the NO donor molsidomine may be due to persistently increased preglomerular resistance. The mechanisms by which increased perinatal NO availability can persistently reprogram kidney function and ameliorate hypertension deserve further study.Keywords
This publication has 49 references indexed in Scilit:
- Maternal Supplementation With Citrulline Increases Renal Nitric Oxide in Young Spontaneously Hypertensive Rats and Has Long-Term Antihypertensive EffectsHypertension, 2007
- Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase CAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Mechanisms of Disease: in utero programming in the pathogenesis of hypertensionNature Clinical Practice Nephrology, 2006
- Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanismsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Sex-Specific Effects of Prenatal Low-Protein and Carbenoxolone Exposure on Renal Angiotensin Receptor Expression in RatsHypertension, 2005
- Perinatal l -Arginine and Antioxidant Supplements Reduce Adult Blood Pressure in Spontaneously Hypertensive RatsHypertension, 2004
- Rapid Child Growth Raises Blood Pressure in Adolescent Boys Who Were Thin at BirthHypertension, 2003
- Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed ratsKidney International, 2002
- Tubuloglomerular feedback and prolonged ACE-inhibitor treatment in the hypertensive fawn-hooded ratNephrology Dialysis Transplantation, 1998
- Relationships Between Sodium Clearance, Plasma Renin Activity, Plasma Aldosterone, Renal Hemodynamics and Blood Pressure in Essential HypertensionClinical and Experimental Hypertension, 1980